“[Cost-Effectiveness Analysis of Peginterferon Beta-1a in Italian Relapsing Remitting Multiple Sclerosis Management]”. 2016. Farmeconomia. Health Economics and Therapeutic Pathways 17 (2S): 13-36. https://doi.org/10.7175/fe.v17i2S.1230.